Everolimus for Advanced, Progressive, Nonfunctional Neuroendocrine Tumors (NET) of the Gastrointestinal (GI) Tract: Efficacy and Safety From a RADIANT-4 Subgroup Analysis


Clinical Advances in Hematology and Oncology H&o 14(5 Suppl. 7): 11-13

2016


ISSN/ISBN: 1543-0790
PMID: 27168106
Accession: 057820372

Download citation:  
Text
  |  
BibTeX
  |  
RIS

Article/Abstract emailed within 1 workday
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal